ATE361755T1 - Verwendung von thrombomodulinanaloga zur regenerierung von rückenmarkverletzungen - Google Patents

Verwendung von thrombomodulinanaloga zur regenerierung von rückenmarkverletzungen

Info

Publication number
ATE361755T1
ATE361755T1 AT01973674T AT01973674T ATE361755T1 AT E361755 T1 ATE361755 T1 AT E361755T1 AT 01973674 T AT01973674 T AT 01973674T AT 01973674 T AT01973674 T AT 01973674T AT E361755 T1 ATE361755 T1 AT E361755T1
Authority
AT
Austria
Prior art keywords
spinal cord
cord injury
regeneration
thrombomodulin analogs
thrombomodulin
Prior art date
Application number
AT01973674T
Other languages
German (de)
English (en)
Inventor
Barry Festoff
Michael Morser
Original Assignee
Paion Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paion Deutschland Gmbh filed Critical Paion Deutschland Gmbh
Application granted granted Critical
Publication of ATE361755T1 publication Critical patent/ATE361755T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/366Thrombomodulin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Ropes Or Cables (AREA)
  • Communication Cables (AREA)
  • Signal Processing Not Specific To The Method Of Recording And Reproducing (AREA)
  • Accommodation For Nursing Or Treatment Tables (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01973674T 2000-08-31 2001-08-31 Verwendung von thrombomodulinanaloga zur regenerierung von rückenmarkverletzungen ATE361755T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22971400P 2000-08-31 2000-08-31
US09/938,405 US20020111296A1 (en) 2000-08-31 2001-08-23 Thrombomodulin analogs for use in recovery of spinal cord injury

Publications (1)

Publication Number Publication Date
ATE361755T1 true ATE361755T1 (de) 2007-06-15

Family

ID=26923554

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01973674T ATE361755T1 (de) 2000-08-31 2001-08-31 Verwendung von thrombomodulinanaloga zur regenerierung von rückenmarkverletzungen

Country Status (13)

Country Link
US (3) US20020111296A1 (cg-RX-API-DMAC7.html)
EP (1) EP1365788B1 (cg-RX-API-DMAC7.html)
JP (1) JP2004521076A (cg-RX-API-DMAC7.html)
AT (1) ATE361755T1 (cg-RX-API-DMAC7.html)
AU (2) AU9322901A (cg-RX-API-DMAC7.html)
CA (1) CA2420900A1 (cg-RX-API-DMAC7.html)
DE (1) DE60128399T2 (cg-RX-API-DMAC7.html)
DK (1) DK1365788T3 (cg-RX-API-DMAC7.html)
ES (1) ES2287161T3 (cg-RX-API-DMAC7.html)
IL (2) IL154600A0 (cg-RX-API-DMAC7.html)
NO (1) NO20030919L (cg-RX-API-DMAC7.html)
PT (1) PT1365788E (cg-RX-API-DMAC7.html)
WO (1) WO2002017953A2 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006005362A1 (en) * 2004-07-13 2006-01-19 Paion Deutschland Gmbh Production of mammalian proteins in plant cells
US20060148695A1 (en) * 2005-01-03 2006-07-06 National Cheng Kung University Novel angiogenic composition and use thereof
US8293710B2 (en) * 2005-01-03 2012-10-23 Blue Blood Biotech Corp. Method for treating wounds using an EGF-like domain of thrombomodulin
WO2007018400A1 (en) * 2005-08-11 2007-02-15 Medigenes Co., Ltd Pharmaceutical composition for the treatment of nerve damage comprising blood plasma or serum
EP2014296A1 (en) * 2007-07-10 2009-01-14 PAION Deutschland GmbH Novel strategies for increasing the reperfusion in obstructed blood vessel
AR067345A1 (es) * 2007-07-10 2009-10-07 Paion Deutschland Gmbh Uso de trombomodulina para la preparacion de un medicamento trombolitico
WO2010006635A1 (en) * 2008-07-16 2010-01-21 Paion Deutschland Gmbh Treatment of inflammatory bowel disease
JP2011527992A (ja) * 2008-07-16 2011-11-10 パイオン ドイチュラント ゲーエムベーハー 放射線傷害の予防および治療
CA2875069C (en) 2012-05-31 2018-01-02 Kinki University Agent for prophylactic and/or therapeutic treatment of peripheral neuropathic pain caused by anticancer agent
CN112839669A (zh) * 2018-09-28 2021-05-25 旭化成制药株式会社 用于减轻由抗恶性肿瘤剂引起的末梢神经障碍的症状和/或抑制其发病的药物
US11497795B2 (en) 2018-09-28 2022-11-15 Asahi Kasei Pharma Corporation Medicament for mitigating conditions and/or suppressing onset of peripheral neuropathy induced by anti-malignant tumor agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466668A (en) * 1989-04-28 1995-11-14 Schering Aktiengesellschaft Superior thrombomodulin analogs for pharmaceutical use
US5256770A (en) * 1990-04-09 1993-10-26 Schering Ag Oxidation resistant thrombomodulin analogs
US6063763A (en) * 1989-04-28 2000-05-16 Schering Aktiengesellschaft Protease-resistant thrombomodulin analogs
JP3789147B2 (ja) * 1995-04-11 2006-06-21 旭化成ファーマ株式会社 脊髄損傷後の神経障害に対する治療剤

Also Published As

Publication number Publication date
US20040002446A1 (en) 2004-01-01
WO2002017953A2 (en) 2002-03-07
DE60128399T2 (de) 2008-01-10
HK1062398A1 (en) 2004-11-05
DK1365788T3 (da) 2007-09-17
US20020111296A1 (en) 2002-08-15
EP1365788B1 (en) 2007-05-09
ES2287161T3 (es) 2007-12-16
WO2002017953A3 (en) 2003-10-09
AU9322901A (en) 2002-03-13
IL154600A0 (en) 2003-09-17
DE60128399D1 (de) 2007-06-21
NO20030919L (no) 2003-04-10
US20090143281A1 (en) 2009-06-04
AU2001293229B2 (en) 2007-04-05
EP1365788A2 (en) 2003-12-03
NO20030919D0 (no) 2003-02-27
CA2420900A1 (en) 2002-03-07
JP2004521076A (ja) 2004-07-15
IL154600A (en) 2009-02-11
PT1365788E (pt) 2007-08-10

Similar Documents

Publication Publication Date Title
EA200600294A1 (ru) [1,8] нафтиридин-2-оны и родственные соединения для лечения шизофрении
DE60325770D1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
ATE401309T1 (de) Verwendung von 2-fuoro-3-ketoestern zur herstellung von 3-fuoro-6,7,8,9-tetrahydro-4h- pyrimidoä1,2-aüpyrimidin-4-onen
ATE428413T1 (de) Neue verwendung von peptidverbindungen zur behandlung ovn zentralen neuropathischen schmerzen
ATE346614T1 (de) Vaginale zusammensetzung enthaltend lidocaine zur behandlung von gebärmutterrhythmusstörung
ATE452655T1 (de) Verwendung von l-polynukleotiden zur diagnostischen bilderzeugung
DE60136477D1 (de) Retinoide zur behandlung von emphysem
ATE449104T1 (de) Verfahren zur reinigung von fibrinogen
ATE361755T1 (de) Verwendung von thrombomodulinanaloga zur regenerierung von rückenmarkverletzungen
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
NO20025405D0 (no) Modulatorer for TNF-alfa-signalisering
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
DE60325194D1 (de) Methoden zur verwendung von lamellaren körpern für therapeutische zwecke
ATE402694T1 (de) Verwendung von 1-phenyl-3-dimethylamino-propan- verbindungen zur therapie der harninkontinenz
DE60219940D1 (de) Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie
DE60213365D1 (de) Verwendung von mglur5 antagonisten zur behandlung von pruritischen zuständen
DE60103503D1 (de) Verwendung von fsh zur behandlung von infertilität
DE60217653D1 (de) Verwendung von melatonin zur behandlung der mit konzentrationsschwäche einhergehenden hyperaktivität
DE50212649D1 (de) Verwendung von desoxypeganin zur behandlung der klinischen depression
ATE347883T1 (de) Verwendung von n-(2-aryl-propionyl)-sulfonamiden zur behandlung von rückenmarkverletzungen
ATE267209T1 (de) Reinigung von carboxaldehyd
DE602004011486D1 (de) Kombinierte verwendung von einem fibrat und von orlistat zur behandlung von obesitas
ATE359088T1 (de) Verwendung von interleukin-18 zur behandlung von uv-assoziierten hautkrankheiten
ATE290874T1 (de) Verwendung von niedermolekularen heparin zur behandlung von osteoarthrose
DE69926996D1 (de) Verwendung von riluzol zur behandlung der retinalischemie

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1365788

Country of ref document: EP

REN Ceased due to non-payment of the annual fee